Temporomandibular Joint Pain and Synovial Fluid Analysis: A Review of the Literature

Journal of Oral and Maxillofacial Surgery

Volumn 67, Issue 11, 2009, Pages 2497-2504

  Bouloux, Gary F ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; DISEASE SEVERITY; INFLAMMATION; MYOFASCIAL PAIN; OSTEOARTHRITIS; PAIN ASSESSMENT; SENSITIVITY AND SPECIFICITY; SYNOVIAL FLUID; SYNOVITIS; TREATMENT RESPONSE;

FACIAL PAIN; HUMANS; INFLAMMATION; PAIN; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 70349859627     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2009.04.103     Document Type: Article

References (76)

1. Schmitz J., Milam S., and Caloss R. Future directions for pain research in oral and maxillofacial surgery: Findings of the 2005 AAOMS research summit. J Oral Maxillofac Surg 63 (2005) 1410
2. Sheets D., Okamoto T., Dijkgraaf L., et al. Free radical damage in facsimile synovium: Correlation with adhesion formation in osteoarthritic TMJs. J Prosthodont 15 (2006) 9
3. Milam S., Zardeneta G., and Schmitz J. Oxidative stress and degenerative temporomandibular joint disease: A proposed hypothesis. J Oral Maxillofac Surg 56 (1998) 214
4. Seki H., Fukuda M., Iino M., et al. Immunohistochemical localization of cyclooxygenase-1 and -2 in synovial tissues from patients with internal derangement or osteoarthritis of the temporomandibular joint. Int J Oral Maxillofac Surg 33 (2004) 687
5. Nitzan D., Kreiner B., and Zeltser R. TMJ lubrication system: Its effect on the joint function, dysfunction, and treatment approach. Compendium 25 (2004) 437
6. Cascone P., Vetrano S., Nicolai G., and Fabiani F. Temporomandibular joint biomechanical restrictions: The fluid and synovial membrane. J Craniofac Surg 10 (1999) 301
7. Takahashi T., Tominaga K., Takano H., et al. A decrease in the molecular weight of hyaluronic acid in synovial fluid from patients with temporomandibular disorders. J Oral Pathol Med 33 (2004) 224
8. Kim S., Park Y., Hong S., et al. The presence of bacteria in the synovial fluid of the temporomandibular joint and clinical significance: Preliminary study. J Oral Maxillofac Surg 61 (2003) 1156
9. Israel H., Langevin J., Singer M., et al. The relationship between temporomandibular joint synovitis and adhesions: Pathogenic mechanisms and clinical implications for surgical management. J Oral Maxillofac Surg 64 (2006) 1066
10. Nitzan D. Rationale and indications for arthrocentesis of the temporomandibular joint. Alpha Omegan 96 (2003) 57
11. Al-Belasy F., and Dolwick M. Arthrocentesis for the treatment of temporomandibular joint closed lock: A review article. Int J Oral Maxillofac Surg 36 (2007) 773
12. Brennan P., and Ilankovan V. Arthrocentesis for temporomandibular joint pain dysfunction syndrome. J Oral Maxillofac Surg 64 (2006) 949
13. Ward P., and Lentsch A. The acute inflammatory response and its regulation. Arch Surg 134 (1999) 666
14. Aghabeigi B., Haque M., Wasil M., et al. The role of oxygen free radicals in idiopathic facial pain. Br J Oral Maxillofac Surg 35 (1997) 161
15. Emshoff R., and Rudisch A. Determining predictor variables for treatment outcomes of arthrocentesis and hydraulic distention of the temporomandibular joint. J Oral Maxillofac Surg 62 (2004) 816
16. Nishimura M., Segami N., Kaneyama K., et al. Prognostic factors in arthrocentesis of the temporomandibular joint: Evaluation of 100 patients with internal derangement. J Oral Maxillofac Surg 59 (2001) 874
17. Bonnet C., and Walsh D. Osteoarthritis, angiogenesis and inflammation. Rheumatology 44 (2005) 7
18. Sato J., Segami N., Nishimura M., et al. Relationship between the expression of vascular endothelial growth factor in synovial tissues and the extent of joint effusion seen on magnetic resonance imaging in patients with internal derangement of the temporomandibular joint. Br J Oral Maxillofac Surg 41 (2003) 88
19. Sato J., Segami N., Suzuki T., et al. The expression of vascular endothelial growth factor in synovial tissues in patients with internal derangement of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93 (2002) 251
20. Sato J., Segami N., Yoshitake Y., et al. Correlations of the expression of fibroblast growth factor-2, vascular endothelial growth factor, and their receptors with angiogenesis in synovial tissues from patients with internal derangement of the temporomandibular joint. J Dent Res 82 (2003) 272
21. Sato J., Segami N., Kaneyama K., et al. Vascular endothelial growth factor concentrations in synovial fluids of patients with symptomatic internal derangement of the temporomandibular joint. J Oral Pathol Med 34 (2005) 170
22. Emshoff R. Clinical factors affecting the outcome of arthrocentesis and hydraulic distension of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100 (2005) 409
23. Emshoff R., Rudisch A., Bosch R., et al. Prognostic indicators of the outcome of arthrocentesis: A short-term follow-up study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96 (2003) 12
24. Weinberg B., Fermor B., and Guilak F. Nitric oxide synthase and cyclooxygenase interactions in cartilage and meniscus: Relationship to joint physiology, arthritis and tissue repair. In: Harris R. (Ed). Inflammation in the Pathogenesis of Chronic Diseases, vol 31 (2007), Springer-Verlag, New York
25. Okazaki J., Kakudo K., Kamada A., et al. Chondroitin sulfate isomers in synovial fluid of healthy and diseased human temporomandibular joints. Eur J Oral Sci 105 (1997) 440
26. 2, hyaluronic acid, and chondroitin-4 and -6 sulfates in the temporomandibular joint synovial fluid of patients with internal derangement. J Oral Maxillofac Surg 56 (1998) 199
27. Shibata T., Murakami K., Kubota E., et al. Glycosaminoglycan components in temporomandibular joint synovial fluid as markers of joint pathology. J Oral Maxillofac Surg 56 (1998) 209
28. Kaneyama K., Segami N., Sun W., et al. Analysis of tumor necrosis factor-a, interleukin-6, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99 (2005) 276
29. Hirota W. Intra-articular injection of hyaluronic acid reduces total amounts of leukotriene C4, 6-keto-prostaglandin F1-α, prostaglandin F2-α and interleukin-1β in synovial fluid of patients with internal derangement in disorders of the temporomandibular joint. Br J Oral Maxillofac Surg 36 (1998) 35
30. Kopp S., Wenneberg B., Haraldson T., et al. The short term effect of intra-articular injections of sodium hyaluronate and corticosteroids on temporomandibular joint pain and dysfunction. J Oral Maxillofac Surg 43 (1985) 429
31. Shi Z., Guo C., and Awad M. Hyaluronate for temporomandibular joint disorders. Cochrane Database Syst Rev 1 (2008) 1
32. Aghabeigi B., Cintra N., Meghji S., et al. Temporomandibular joint synovial sampling: Estimation of dilutional factor using calcium ion concentration. Int J Oral Maxillofac Surg 31 (2002) 646
33. Alstergren P., Kopp S., and Theodorsson E. Synovial fluid sampling from the temporomandibular joint: Sample quality criteria and levels of interleukin-1β and serotonin. Acta Odontol Scand 57 (1999) 16
34. Alstergren P., Ernberg M., Kvarnstrom M., et al. Interleukin-1β in synovial fluid from the arthritic temporomandibular joint and its relation to pain, mobility, and anterior open bite. J Oral Maxillofac Surg 56 (1998) 1059
35. Nordahl S., Alstergren P., Eliasson S., et al. Interleukin-1β in plasma and synovial fluid in relation to radiographic changes in arthritic temporomandibular joints. Eur J Oral Sci 106 (1998) 559
36. Suzuki T., Segami N., Kaneyama K., et al. Specific expression of interleukin-1β in temporomandibular joints with internal derangement: Correlation with clinical findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88 (1999) 413
37. Kaneyama K., Segami N., Nishimura M., et al. Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders. Br J Oral Maxillofac Surg 40 (2002) 418
38. Sato J., Segami N., Nishimura M., et al. Expression of interleukin 6 in synovial tissues in patients with internal derangement of the temporomandibular joint. Br J Oral Maxillofac Surg 41 (2003) 95
39. Kubota E., Kubota T., Matsumoto J., et al. Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease. J Oral Maxillofac Surg 56 (1998) 192
40. Kaneyama K., Segami N., Sato J., et al. Interleukin-6 family of cytokines as biochemical markers of osseous changes in the temporomandibular joint disorders. Br J Oral Maxillofac Surg 42 (2004) 246
41. Shinoda C., and Takaku S. Interleukin-1β, interleukin-6, and tissue inhibitor of metalloproteinase-1 in the synovial fluid of the temporomandibular joint with respect to cartilage destruction. Oral Dis 6 (2000) 383
42. Nishimura M., Segami N., Kaneyama K., et al. Proinflammatory cytokines and arthroscopic findings of patients with internal derangement and osteoarthritis of the temporomandibular joint. Br J Oral Maxillofac Surg 40 (2002) 68
43. Sandler N., Buckley M., Cillo J., and Braun T. Correlation of inflammatory cytokines with arthroscopic findings in patients with temporomandibular joint internal derangements. J Oral Maxillofac Surg 56 (1998) 534
44. Kacena M., Merrel G., Konda S., et al. Inflammation and bony changes at the temporomandibular joint. Cells Tissues Organs 169 (2001) 257
45. Sato J., Segami N., Nishimura M., et al. Expression of interleukin 8 in synovial tissues in patients with internal derangement of the temporomandibular joint and its relationship with clinical variables. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 (2007) 467
46. Kaneyama K., Segami N., Sato J., et al. Expression of osteoprotegerin in synovial tissue and degradation of articular cartilage: Comparison with arthroscopic findings of temporomandibular joint disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96 (2003) 258
47. Kaneyama K., Segami N., Nishimura M., et al. Osteoclastogenesis inhibitory factor/osteoprotegerin in synovial fluid from patients with temporomandibular disorders. Int J Oral Maxillofac Surg 32 (2003) 404
48. Ping-Ke F., Xu-Chen M., Da-Long M., et al. Determination of interleukin-1 receptor antagonist, interleukin-10, and transforming growth factor-β1 in synovial fluid aspirates of patients with temporomandibular disorders. J Oral Maxillofac Surg 57 (1999) 922
49. Fredriksson L., Alstergren P., and Kopp S. Tumor necrosis factor-a in temporomandibular joint synovial fluid predicts treatment effects on pain by intra-articular glucocorticoid treatment. Mediat Inflamm 6 (2006) 1
50. Emshoff R., Puffer P., Strobl H., and Gabner R. Effect of temporomandibular joint arthrocentesis on synovial fluid mediator level of tumor necrosis factor-α: Implications for treatment outcome. Int J Oral Maxillofac Surg 29 (2000) 176
51. Emshoff R., Puffer P., Rudisch A., and Gabner R. Temporomandibular joint pain: Relationship to internal derangement type, osteoarthrosis, and synovial fluid mediator level of tumor necrosis factor-α. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90 (2000) 442
52. Uehara J., Kuboki T., Fujisawa T., et al. Soluble tumour necrosis factor receptors in synovial fluids from temporomandibular joints with painful anterior disc displacement without reduction and osteoarthritis. Arch Oral Biol 49 (2004) 133
53. Nishimura M., Segami N., Kaneyama K., et al. Comparison of cytokine level in synovial fluid between successful and unsuccessful cases in arthrocentesis of the temporomandibular joint. J Oral Maxillofac Surg 62 (2004) 284
54. Takahashi T., Kondoh T., Ohtani T., et al. Association between arthroscopic diagnosis of temporomandibular joint osteoarthritis and synovial fluid nitric oxide levels. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88 (1999) 129
55. Alpaslan C., Bilgihan A., Alpaslan G., et al. Effect of arthrocentesis and sodium hyaluronate injection on nitrite, nitrate and thiobarbituric acid-reactive substance levels in the synovial fluid. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89 (2000) 686
56. Zardeneta G., Milam S., and Schmitz J. Iron-dependent generation of free radicals: Plausible mechanisms in the progressive deterioration of the temporomandibular joint. J Oral Maxillofac Surg 58 (2000) 302
57. 2, and substance P level in synovial fluid between successful and unsuccessful cases. J Oral Maxillofac Surg 65 (2007) 242
58. Nishimura M., Segami N., Kaneyama K., et al. Relationships between pain related mediators and both synovitis and joint pain in patients with internal derangements and osteoarthritis of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94 (2002) 328
59. Kaneyama K., Segami N., Nishimura M., et al. The ideal lavage volume for removing bradykinin, interleukin-6, and protein from the temporomandibular joint by arthrocentesis. J Oral Maxillofac Surg 62 (2004) 657
60. Arinci A., Ademoglu E., Aslan A., et al. Molecular correlates of temporomandibular joint disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99 (2005) 666
61. Sato J., Segami N., Yoshitake Y., et al. Specific expression of substance P in synovial tissues of patients with symptomatic, non-reducing internal derangement of the temporomandibular joint: Comparison with clinical findings. Br J Oral Maxillofac Surg 45 (2007) 372
62. Kajii T., Okamoto T., Yura S., et al. Elevated levels of β-endorphin in temporomandibular joint synovial lavage fluid of patients with closed lock. J Orofac Pain 19 (2005) 41
63. Sato J., Segami N., Yoshitake Y., et al. Expression of capsaicin receptor TRPV-1 in synovial tissues of patients with symptomatic internal derangement of the temporomandibular joint and joint pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100 (2005) 674
64. Kopp S. The influence of neuropeptides, serotonin, and interleukin 1β on temporomandibular joint pain and inflammation. J Oral Maxillofac Surg 56 (1998) 189
65. Sato J., Segami N., Kaneyama K., et al. Relationship of calcitonin gene-related peptide in synovial tissues and temporomandibular joint pain in humans. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 (2004) 533
66. Kaneyama K., Segami N., Sato J., et al. Expression of receptor activator of nuclear factor-kappa B ligand in synovial tissue: Comparison with degradation of articular cartilage in temporomandibular joint disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104 (2007) e12
67. Sato J., Segami N., Kaneyama K., et al. Levels of fibroblast growth factor 2 in synovial fluids in human patients with internal derangement of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96 (2003) 673
68. Segami N., Miyamaru M., Nishimura M., et al. Does joint effusion on T2 magnetic resonance images reflect synovitis?. Part 2. Comparison of concentration levels of pro-inflammatory cytokines and total protein in synovial fluid of the temporomandibular joint with internal derangements and osteoarthrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94 (2002) 515
69. Guler N., Uckan S., Imirzalioglu P., et al. Temporomandibular joint internal derangement: Relationship between joint pain and MR grading of effusion and total protein concentration in the joint fluid. Dentomaxillofac Radiol 34 (2005) 175
70. Takahashi T., Nagai H., Seki H., et al. Relationship between joint effusion, joint pain, and protein levels in joint lavage fluid of patients with internal derangement and osteoarthritis of the temporomandibular joint. J Oral Maxillofac Surg 57 (1999) 1187
71. Westesson P., and Brooks S. Temporomandibular joint: Relationship between MR evidence of effusion and the presence of pain and disc displacement. Am J Radiol 159 (1992) 559
72. Larheim T., Katzberg R., Westesson P., et al. MR evidence of temporomandibular joint fluid and condyle marrow alterations: Occurrence in asymptomatic volunteers and symptomatic patients. Int J Oral Maxillofac Surg 30 (2001) 113
73. Kaneyama K., Segami N., Sun W., et al. Levels of soluble cytokine factors in temporomandibular joint effusions seen on magnetic resonance images. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99 (2005) 411
74. Zardeneta G., Milam S., Lee T., et al. Detection and preliminary characterization of matrix metalloproteinase activity in temporomandibular joint lavage fluid. Int J Oral Maxillofac Surg 27 (1998) 397
75. Flygare L., Wendel M., Saxne T., et al. Cartilage matrix macromolecules in lavage fluid of temporomandibular joints before and 6 months after diskectomy. Eur J Oral Sci 105 (1997) 369
76. Ishimaru J., Ogi N., Mizuno S., and Goss A. Quantitation of chondroitin-sulfates, disaccharides and hyaluronan in normal, early and advanced osteoarthritic sheep temporomandibular joints. Osteoarthritis Cartilage 9 (2001) 365